Abstract
Background
Survey data has suggested a gap between individuals willing to participate in a clinical trial and those who enroll. Clearer research must be done to better understand this discrepancy and the accessibility of patient-desired information, such that steps can be identified to assist sponsors in empowering patients to drive their own clinical trial search journey.
Methods
Patients, sponsors, and health care professionals were engaged through surveys and advisory boards to determine the ideal information for sponsors to provide during a clinical trial search. Public registries were analyzed to assess availability of basic investigator and site contact location information.
Results
Data reiterated the need for patients to have easy and unambiguous methods of connecting with the clinical trial site. Analysis of data on registries prove that sponsors have the opportunity to better utilize contact information on databases to enable a patient’s clinical trial search journey.
Conclusions
More robust disclosure of site location and contact details on public registries could lay the foundation for a more user-friendly clinical trial search. Allowing sites autonomy in site contact methods while promoting accessibility will facilitate the connection of interested patients with appropriate trial opportunities.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ogino D, Takahashi K, Sato H. Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network. Trials. 2014;15:428.
Hudson KL, Lauer MS, Collins FS. Toward a new era of trust and transparency in clinical trials. JAMA. 2016;316:1353–1354.
Center for Information and Study on Clinical Research Participation (CISCRP). 2015 Perceptions and Insights Study. https://www.ciscrp.org/our-programs/research-services/perceptions-insights-studies/. Accessed January 2, 2017.
ClinicalTrials.gov website. https://clinicaltrials.gov/. Accessed March 8, 2017.
Godlew BJ, Furlong P. Transparency as a means to increase clinical trial enrollment. Drug Inf J. 2010;44:265–270.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Polidori, C.P., Su, M.S., Jakee, K. et al. Improving Investigative Site Contact Options on Clinical Trial Registries: Making It Easier for Patients to Find Clinical Trials. Ther Innov Regul Sci 51, 534–541 (2017). https://doi.org/10.1177/2168479017720474
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479017720474